Blog Viewer

Open Comment Periods for SITC’s Gynecologic Cancer and Gastrointestinal Cancer Guidelines Close January 27

By SITC Scientific Publications News posted 01-12-2023 09:46

  

The Society for Immunotherapy of Cancer (SITC) is pleased to invite public comment on two new draft clinical practice guidelines (CPGs):

  • “Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer”
  • “Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer”


During SITC’s open comment period, key stakeholders and other experts in the field may critically review a confidential copy of the CPG draft and provide input prior to its publication. More information on how to gain access to the draft manuscript can be found on the open comment page of the SITC website. All comments are due to SITC by January 27.

The manuscripts are part of the broader SITC Cancer Immunotherapy Guidelines program that has produced a collection of CPGs developed by multidisciplinary panels of experts who draw from practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and consensus-based recommendations on how to use immunotherapy to help improve outcomes for patients with cancer. You may read the entire series of CPGs in the Journal for ImmunoTherapy of Cancer (JITC), the society’s open access, peer-reviewed online journal.

If you have questions about the open comment periods for these two CPGs or would like more details about the SITC’s other immunotherapy CPGs, please email scientificresources@sitcancer.org.


Permalink